Tag: Prescription Drugs
Nab-Paclitaxel, Pembrolizumab Combo Active in Advanced Urothelial Cancer
Overall response rate 50 percent among 36 patients with platinum-refractory or cisplatin-ineligible advanced urothelial cancer
Antiepileptic Med Use Increasing in Nursing Home Residents With Dementia
The two most common, valproic acid and gabapentin, being used in clinically distinct ways
ASN: Empagliflozin Cuts Risk for Progression in CKD
Risk for progression of kidney disease or death from cardiovascular causes reduced with empagliflozin versus placebo
ASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
No difference seen with discontinuation, continuation of RAS inhibitors among patients with advanced, progressive chronic kidney disease
Links Explored Between Antidiabetic Meds, Multiple Sclerosis Risk
Association between exposure to antihyperglycemic medications for type 2 diabetes and risk for developing multiple sclerosis differs according to age and sex
AHA: Baxdrostat Studied in Treatment-Resistant Hypertension
Dose-dependent reductions in systolic blood pressure seen in phase 2 dose-ranging study
AHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM
In patients with T2DM, hypertriglyceridemia, and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo
Lipid-Lowering, Antidiabetic Drugs Tied to Prevalence of AMD
Use of lipid-lowering drugs, antidiabetic drugs associated with lower prevalence of any age-related macular degeneration
Telmisartan Linked to Reduced Risk for Alzheimer Disease in Black Patients
African American-specific beneficial effects of telmisartan identified in Mendelian randomization analysis
ENT-01 Safe, Improves Constipation in Patients With Parkinson Disease
Improvement seen in weekly complete spontaneous bowel movement rate and in secondary end points
